醫師學術論文
Paper張議徽 Yi-Huei Chang 主治醫師
張議徽醫師於中國醫藥大學附設醫院完成泌尿科專科醫師訓練並升任主治醫師,其專長為:
1.攝護腺肥大、尿路結石、性功能障礙
2.泌尿腫瘤(攝護腺癌、膀胱癌、腎癌等)
3.手術專精: 達文西機器手臂手術、攝護腺雷射(綠光)手術、軟式輸尿管鏡、微創疝氣手術、包皮槍手術、無痛結紮手術
4.腎臟移植專科醫師
分院掛號
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | 曾浩翔(CHEN HAO XIANG)、蔡禮賢(Li-Hsien,Tsai)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin)、葉士芃(Shih-Peng Yeh)、連啟舜(Chi-Shun Lien)、楊啟瑞(Chi-Rei Yang)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、謝博帆(Hsieh, Po-Fan)*、黃志平(Chi-Ping Huang)*,Enzalutamide prior to radium-223 is associated with better overall survival in metastatic castration-resistant prostate cancer patients compared to abiraterone - a retrospective study,Cancers,2023 Jul,15(13):3516-3516 | 2023 . 07 |
2 | 潘思穎(Szu-Ying Pan)、陳汶吉(Wen-Chi Chen)、黃志平(Chi-Ping Huang)、許重義(Chung Y Hsu)、張議徽(Yi-Huei Chang)*,The Association of Prostate Cancer and Urinary Tract Infections: A New Perspective of Prostate Cancer Pathogenesis,Medicina-Lithuania,2023 Mar,59(): | 2023 . 03 |
3 | 張議徽(Yi-Huei Chang)、潘思穎(Szu-Ying Pan)、林佳瑜(LIN CHIA-YU)、黃志平(Chi-Ping Huang)、鍾季容(Chi-Jung Chung)、陳永祥(Chen, Yung-Hsiang)*、陳汶吉(Wen-Chi Chen)*,Factors Deciding Conservative or Intervention Treatment for Prostate Abscess: A Retrospective Case-Control Study,Journal of Personalized Medicine,2023 Mar,13():484 | 2023 . 03 |
4 | 謝博帆(Hsieh, Po-Fan)、李柏毅(LI PO-I)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、黃志平(Chi-Ping Huang)*,Learning Curve of Transperineal MRI/US Fusion Prostate Biopsy: 4-Year Experience,Life-Basel,2023 Feb,13():638 | 2023 . 02 |
5 | (Henry H Woo)、黃志平(Chi-Ping Huang)、黃志賢(William J. H)、張議徽(Yi-Huei Chang)、連啟舜(Chi-Shun Lien)、(Archil Chkhotua)、(Dean S Elterman)*,The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH),PROSTATE CANCER AND PROSTATIC DISEASES,2022 May,0(): | 2022 . 05 |
6 | 謝博帆(Hsieh, Po-Fan)、張天佑(Tian-Yu Jhang)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、吳錫金(Hsi-Chin Wu)*,Saturation Target Biopsy can Overcome the Learning Curve of Magnetic Resonance Imaging/Ultrasound Fusion Biopsy of the Prostate,Journal of Mens Health,2022 May,18(6):127 | 2022 . 05 |
7 | 謝博帆(Hsieh, Po-Fan)、張天佑(Tian-Yu Jhang)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、吳錫金(Hsi-Chin Wu)*,A comparative study of transperineal software-assisted magnetic resonance/ ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate,BMC Urology,2022 Apr,22():72 | 2022 . 04 |
8 | 林詩怡(Shih-Yi Lin)、林橙莉(Cheng-Li Lin)、張詩聖(Shih-Sheng Chang)、張議徽(Yi-Huei Chang)、徐武輝(Wu-Huei Hsu)、林正介(Cheng-Chieh Lin)、高嘉鴻(Chia-Hung Kao)*,Risk of diabetes mellitus in patients with prostate cancer receiving injection therapy: A nationwide population-based propensity score-matched study,INTERNATIONAL JOURNAL OF CLINICAL PRACTICE,2021 Sep,75(9):e14416 | 2021 . 09 |
9 | 莊伯恒(Po-Heng Chuang)、張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)*、鄒頡龍(Chieh-Lung Chou)*,Diagnostic potential of Low Serum Platelet, Albumin and prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis,Journal of Clinical Medicine,2021 Jun,(): | 2021 . 06 |
10 | 林維卿(Wei-Ching Lin)、張兆祥(Chao-Hsiang Chang)、張議徽(Yi-Huei Chang)、林建亨(Chien-Heng Lin)*,Three-dimensional Reconstruction of Renal Vascular Tumor Anatomy to facilitate accurate preoperative planning of partial nephrectomy,BioMedicine,2020 Dec,10(4):36-41 | 2020 . 12 |
11 | 黃志平(Chi-Ping Huang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、楊啟瑞(Chi-Rei Yang)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、王又平(Yu-Ping Wang)、王又德(Yu-De Wang)*,External validation of the Simplified PADUA REnal (SPARE) nephrometry system in predicting surgical outcomes after partial nephrectomy,BMC Urology,2020 Sep,20(1):146 | 2020 . 09 |
12 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、黃志平(Chi-Ping Huang)、吳錫金(Hsi-Chin Wu)、謝博帆(Po-Fan Hsieh)*、鄒頡龍(Chieh-Lung Chou)*,A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients,Toxins,2020 Jun,12(6):365-365 | 2020 . 06 |
13 | 謝博帆(Po-Fan Hsieh)、李瑋涓(Li, Wei-Juan)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、吳錫金(Hsi-Chin Wu)*,Combining Prostate Health Index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population,WORLD JOURNAL OF UROLOGY,2019 Aug,.(.):.-. | 2019 . 08 |
14 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、黃志平(Huang, Chi-Ping)*、沈德群(Te-Chun Shen)*,A Huge Cavity in the Right Upper Abdomen,BRITISH JOURNAL OF HOSPITAL MEDICINE,2019 Mar,80(3):173-173 | 2019 . 03 |
15 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、林精湛(Ching-Chan Lin)*、張兆祥(Chang,Chao-Hsiang)、葉士芃(Su-Peng Yeh),Outcomes of Stage II to IV Upper Tract Urothelial Carcinoma and Adjuvant Chemotherapy for Localized Advanced cancer,Oncology Letters,2019 Jan,17(1):1341-1348 | 2019 . 01 |
16 | 謝博帆(Po-Fan Hsieh)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、黃志平(Chi-Ping Huang)、陳汶吉(Wen-Chi Chen)、葉進仲(Chin-Chung Yeh)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Kuo-Liang Chen)、連啟舜(Chi-Shun Lien)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、吳錫金(Hsi-Chin Wu)*,Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4e10 ng/mL,KAOHSIUNG JOURNAL OF MEDICAL SCIENCES,2018 Aug,34():461-466 | 2018 . 08 |
17 | 陳冠亨(Guang-Heng Chen)、王曦賢(Hsi-Hsien Wang)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、李聖偉(Sheng-Wei Li)、黃志平(Huang, Chi-Ping)、葉進仲(Yeh, Chin-Chung)、張兆祥(Chang, Chao-Hsiang)*,Evaluation of the relationship and postoperative glomerular filtration rate between the living donor and the recipients in kidney transplantation,Urological Science,2017 Dec,28(4):227-231 | 2017 . 12 |
18 | 張兆祥(Chang, Chao-Hsiang)、邱鴻傑(Hung-Chieh Chiu)、林維卿(Lin, Wei-Ching)、何子龍(Tzu-Lung Ho)、張菡(Chang, Han)、張議徽(Yi-Huei Chang)、黃志平(Huang, Chi-Ping)、吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、謝博帆(Po-Fan Hsieh)*,The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy,Biomed Research International,2017 Oct,2017():1-6 | 2017 . 10 |
19 | 張議徽(Yi-Huei Chang)、蕭子玄(SIU JUSTIN JI-YUEN)、蕭博任(Po-Jen Hsiao)、張兆祥(Chang, Chao-Hsiang)、鄒頡龍(Chou, Chieh-Lung)*,Review of underactive bladder,JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,2017 Sep,(): | 2017 . 09 |
20 | 蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、張議徽(Yi-Huei Chang)、張兆祥(Chang,Chao-Hsiang)*、張菡(Han Chang)、白禮源(Li-Yuan Bai),An unresectable retroperitoneal malignant fibrous histiocytoma: a case report,Oncology Letters,2016 Apr,11(4):2403-2407 | 2016 . 04 |
21 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、張兆祥(Chang,Chao-Hsiang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)*、鍾季容(Chi-Jung Chung)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Chen, Kuo-Liang),Economic fluctuation affects vasectomy utilization: A single-institution study,Urological Science,2015 Sep,26(3):214-217 | 2015 . 09 |
22 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、黃志平(Chi-Ping Huang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、張兆祥(Chang,Chao-Hsiang)*,The value of cystography in the prediction of early urinary continence after radical prostatectomy,Urological Science,2015 Aug,(): | 2015 . 08 |
23 | 鍾季容(Chi-Jung Chung)、張兆祥(Chang,Chao-Hsiang)、褚志斌(Chih-Pin Chuu)、楊啟瑞(Che-Rei Yang)、張議徽(Yi-Huei Chang)、黃志平(Chi-Ping Huang)、陳汶吉(Chen, Wen-Chi)、(Mu-Chi Chung)、張菡(Han Chang)*,Reduced 5-Methylcytosine Level as a Potential Progression Predictor in Patients with T1 or Non-Invasive Urothelial Carcinoma,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2015 Jan,16():677-690 | 2015 . 01 |
24 | 陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、陳至正(Chi-Cheng Chen)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、陳國樑(Chen, Kuo-Liang)、鄒頡龍(Chieh-Lung Chou)、陳汶吉(Chen, Wen-Chi)、張兆祥(Chang,Chao-Hsiang)*,Spontaneous ureteral rupture and review of the literature,AMERICAN JOURNAL OF EMERGENCY MEDICINE,2014 Jul,32(7):772-774 | 2014 . 07 |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | Real World Experience of Enfortumab vedotin in Advanced Urothelial Carcinoma: Preliminary results in a Single Center,2024 台灣泌尿科醫學會年會,林口長庚醫院長庚國際會議中心,2024.08.16~2024.08.18, | 2024 . 08 |
2 | The role of SPARE nephrometry and tumor contact surface area in predicting malignancy and aggressiveness of clinical T1 tumors treated with partial nephrectomy,第110屆日本泌尿外科醫協會年會 (JUA),日本神戶,2023.04.20~2023.04.23, | 2023 . 04 |
3 | Radium-223 after docetaxel has similar efficacy and safety profile compared to docetaxel naive in mCRPC patient,2023日本泌尿科醫學會年會,Kobe Conventional Center,2023.04.20~2023.04.23, | 2023 . 04 |
4 | The real-world outcome with abiraterone acetate in Asian men with metastatic castrate-resistant prostate cancer treated in China Medical University Hospital,The 110th Annual Meeting of the Janaese Urological Association,Kobe Convention Center, Japan,2023.04.20~2023.04.23, | 2023 . 04 |
5 | 亞洲轉移性去勢療法無效前列腺癌於中國醫藥大學附設醫院以安可坦治療之預後與相關結果,2023 TUA 半年會,福容大飯店淡水漁人碼頭店,2023.02.04~2023.02.04, | 2023 . 02 |
6 | 亞洲轉移性去勢療法無效前列腺癌於中國醫藥大學附設醫院以澤珂併用類固醇治療之預後與相關結果,2022 TUA Annual Meeting,高雄萬豪酒店,2022.08.20~2022.08.21, | 2022 . 08 |
7 | Minimal invasive surgery for the treatment of ureteral endometriosis related obstructive uropathy – a single-center experience,2022 台灣泌尿科醫學會年會,高雄萬豪酒店,2022.08.20~2022.08.21, | 2022 . 08 |
8 | External validation of pre-operative nomogram for prediction of non- organ confined upper urinary tract urothelial carcinoma in central Taiwan population,2022 台灣泌尿科醫學會年會,高雄萬豪酒店,2022.08.20~2022.08.21, | 2022 . 08 |
9 | Improvement on semen parameter in infertile varicocele patients receiving microscopic varicocelectomy compared with conventional varicocelectomy,2022 台灣泌尿科醫學會年會-國際會議ISTUA,高雄萬豪酒店,2022.08.20~2022.08.21, | 2022 . 08 |
10 | Radium-223 for mCRPC: Real-world experience of a single-center,2021 台灣泌尿科醫學會年會,台中榮總,2021.12.25~2021.12.26, | 2021 . 12 |
11 | ,update androgen deprivation therapy in advanced prostate cancer,裕元花園酒店4F東側包廂,2021.12.11~2021.12.11,Are all GNRH agonists equivalence for the treatment of prostate cancer? A systematic review. | 2021 . 12 |
12 | A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients,第十五屆泛太平洋尿控學會年會the 15th pan-pacific continence society meeting,高雄萬豪酒店(與日本視訊會議),2021.09.11~2021.09.12, | 2021 . 09 |
13 | ,TUA 桃喜泌尿腫瘤會議,桃園喜來登酒店,2020.10.24~2020.10.25,Novel hormone therapy for the mCRPC patients | 2020 . 10 |
14 | The role of tumor contact surface area and SPARE nephrometry in predicting malignancy and aggressiveness of clinical T1 tumors treated with partial nephrectomy,2022 International Session of TUA Conference,高雄醫學大學,2020.08.20~2020.08.20, | 2020 . 08 |
15 | Analyze influential factors of patients with prostate abscess underwent conservative or intervention treatment and prognosis of either treatment,TUA2020,臺大醫院國際會議中心,2020.08.21~2020.08.23, | 2020 . 08 |
16 | Neoadjuvant chemotherapy and adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma,台灣泌尿科醫學會年會,台大,2020.08.21~2020.08.23, | 2020 . 08 |
17 | ,台灣泌尿科醫學會年會,台大國際會議中心,2020.08.21~2020.08.23,Role of perioperative chemotherapy in T3 UTUC disease in Taiwan | 2020 . 08 |
18 | ,2020 GU cancer symposium,台南和逸飯店,2020.06.13~2020.06.14,Real world experience after reimbursement renal function relaxation | 2020 . 06 |
19 | Dual Kidney Transplantation: the Renal Graft Function Will Improve, Just Like a Sleeping Beauty Worth Waiting for,第三屆全球華人腎臟病學術大會,南京國際青年文化中心,2019.12.05~2019.12.08, | 2019 . 12 |
20 | Peripheral CD4 and CD8 Counts as guidance for Anti-ThymoGlobulin Dosage in Kidney Transplantation—A proposed new approach,Asia Pacific AKI to/on CKD Summit in conjunction with 台灣腎臟醫學會108年會員大會暨學術演講會,台大國際會議中心,2019.11.22~2019.11.24, | 2019 . 11 |
21 | 腹腔鏡及機器手臂腎輸尿管切除術用於第三四期尿路上皮癌的預後比較,108年度台灣泌尿科醫學會年會,台中中國醫藥大學立夫教學大樓5樓504室,2019.08.17~2019.08.18, | 2019 . 08 |
22 | Outcome of lymph node dissection in renal pelvis urothelial carcinoma,台灣泌尿科醫學會年會,中國附醫,2019.08.16~2019.08.18, | 2019 . 08 |
23 | Adjuvant chemotherapy in T3/T4 upper urinary tract urothelial carcinoma—CMUH experience,台灣泌尿科醫學會年會國際場 ISTUA,中國附醫,2019.08.16~2019.08.18, | 2019 . 08 |
24 | ,第六次全台 UTUC 季會議,臺中高鐵食堂-大會議室,2019.07.20~2019.07.20,中國醫藥大學附設醫院資料庫建構現況 | 2019 . 07 |
25 | ,中區泌尿月會,中國醫藥大學附設醫院 癌症中心大樓 癌症中心大樓 癌症中心大樓 癌症中心大樓 1 樓 階梯會議室,2019.06.8 ~2019.06.8 ,I/O for metastatic UC: CMUH experience sharing | 2019 . 06 |
26 | ,2019 高杏泌尿論壇,地點:台南趣淘漫旅(台南市楠西區密枝里密枝102-5號 TEL:06-5753333),2019.06.22~2019.06.23,Systemic Treatment for Non-Clear Cell Renal Cell Carcinoma | 2019 . 06 |
27 | Prognostic values and treatment responses evaluated with lymphovascular invasion, perineural permeation and histologic transformation for urothelial cancer評估泌尿上皮細胞癌淋巴血管侵犯>周邊神經滲透及組織學轉變的預後價值和治療反應,第二十四屆台灣癌症聯合學術年會,格萊天漾大飯店(台北市萬華區艋舺大道101號),2019.05.04~2019.05.05, | 2019 . 05 |
28 | Multiparametric Magnetic Resonance Imaging increases predictive accuracy of oncological outcomes after robot-assisted radical prostatectomy,台灣泌尿科醫學會年會,台北榮總,2018.08.18~2018.08.19, | 2018 . 08 |
29 | Predictive Factors of Necessity of PCN Insertion on Acute Stone Obstructive Pyelonephritis,The 37th Congress of the Societe Internationale d'Urologie,Centro de congressos de lisboa,2017.10.19~2017.10.22, | 2017 . 10 |
30 | predictive markers for the prognosis of muscle invasive bladder cancer treated with neoadjuvant chemotherapy,泌尿科醫學會年會,高雄長庚,2017.08.19~2017.08.20, | 2017 . 08 |
31 | Comparison of Treatment of Large Proximal Ureteral Stones Laparoscopic Ureterolithotomy Versus Percutaneous Nephrolithotomy Versus Ureteroscopic Lithotripsy,WCE 2016,The Cape Town International Convention Centre, Cape Town, South Africa,2016.11.08~2016.11.12,URS outcomes | 2016 . 11 |
32 | Robot-Assisted Anatrophic Nephrolithotomy for complete staghorn stone: case series in China Medical University Hospital,104th Annual Meeting of the Japanese Urological Association,Sendai,2016.04.23~2016.04.25,Urolithiasis | 2016 . 04 |
33 | Robotic assist rectal GIST resection with radical prostatectomy,32屆世界泌尿內視鏡醫學大會32nd World Congress of Endourology and SWL(WCE 2014),台北國際會議中心,2014.09.03~2014.09.07, | 2014 . 09 |
34 | The effect of cigarette smoking and DNA methyltransferase genes polymorphisms on urothelial carcinoma risk in Taiwan,Environment and Health– Bridging South, North, East and West.,Basel, Switzerland,2013.08.19~2013.08.23, | 2013 . 08 |
35 | Low 5-methylcytosine expression as an aggressive biomarker for the urothelial carcinoma: an immunohistochemical study,Molecular Medicine Conference 2012,Mahidol University,2012.12.19~2012.12.22, | 2012 . 12 |
專書
暫無資料研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 個別型,DMR-113-140,張議徽(Yi-Huei Chang)、鍾季容(Chi-Jung Chung),本校(含附醫),多基因風險、重金屬暴露與膀胱癌治療及預後之相關性,2023.8.1~2024.7.31 | 2023 . 08 |
2 | 個別型,A1051222-107,邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(Tzu-Liang Chen)、柯道維(Tao-Wei Ke)、王輝明(Hwei-Ming Wang)、陳宏彰(Hung-Chang Chen)、黃郁純(Yu-Chuen Huang)、花俊宏(Chun-Hung Hua)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、吳錫金(Hsi-Chin Wu)、黃志平(Chi-Ping Huang)、蔡宗欣(Tzong-Shin Tzai)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、吳建廷(Chen-Teng Wu)、劉良智(Liang-Chih Liu)、吳曜充(Yao-Chung Wu)、陳芝蓉(Chih-Jung Chen)、鄭書(Yu-Shu Cheng)、方信元(Hsin-Yuan Fang)、夏德椿(Te-Chun Hsia)、李嘉翔(Chia-Hsiang Li)、陳鴻仁(Hung-Jen Chen)、劉秋松(Chiu-Shong Liu)、陳毓隆(Yu-Lung Chen)、王中儀(JONG-YI WANG),衛福部,全方位癌症照護醫病共享決策輔助工具介入及其效益評估(106-107年) 107年後續擴充,2018.10.5~2019.10.4 | 2018 . 10 |
3 | 國家型,A1051222,邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(William Tzu-Liang Chen)、柯道維(TAO-WEI KE)、花俊宏(Chun-Hung Hua)、張兆祥(Chang,Chao-Hsiang)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、劉良智(Liu, Liang-Chih)、吳曜充(Yao-Chung Wu)、方信元(Hsin-Yuan Fang)、夏德椿(Te-Chun Hsia)、李嘉翔(Chia-Hsiang Li)、黃郁純(YU-CHUEN HUANG)、王中儀(JONG-YI WANG),衛福部,全方位癌症照護醫病共享決策輔助工具介入及其效益評估(106-107年),2017.2.16~2018.2.15 | 2017 . 02 |
4 | 臨床試驗與研究計畫,CMUH106-REC2-121,吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、陳冠亨(Guang-Heng Chen)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、葉士芃(Yeh, Su-Peng)、林哲弘(Che-Hung Lin),附醫廠商計畫,PARACHUTE:Pazopanib治療各種狀況晚期腎細胞癌患者之臨床療效及安全性實務評估;一項前瞻性、非介入性、觀察性研究,2017.1.1~2017.12.31 | 2017 . 01 |
5 | 臨床試驗與研究計畫,CMUH106-REC3-081,張兆祥(Chang, Chao-Hsiang)、張議徽(Yi-Huei Chang)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、林哲弘(Che-Hung Lin)、葉士芃(Yeh, Su-Peng),附醫廠商計畫,一項第III期、隨機分配、雙盲、安慰劑對照的多中心試驗,針對無症狀或有輕度症狀且先前未曾接受治療的轉移性去勢抗性前列腺癌成人男性患者,給予IPATASERTIB併用ABIRATERONE和PREDNISONE/PREDNISOLONE或安慰劑併用ABIRATERONE和PREDNISONE/PREDNISOLONE進行比較,2017.1.1~2017.12.31 | 2017 . 01 |
6 | 臨床試驗與研究計畫,CMUH106-REC2-087,張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、張議徽(Yi-Huei Chang)、葉士芃(Yeh, Su-Peng)、林哲弘(Che-Hung Lin),附醫廠商計畫,一項第二期試驗,針對患有轉移性去勢療法無效之攝護腺癌,同時帶有DNA修復基因異常的男性患者,評估Niraparib的療效和安全性,2017.1.1~2017.12.31 | 2017 . 01 |
7 | 臨床試驗與研究計畫,CMUH106-REC2-099,葉士芃(Yeh, Su-Peng)、吳錫金(Wu, Hsi-Chin)、張議徽(Yi-Huei Chang)、楊啟瑞(Yang, Che-Rei)、蕭博任(Po-Jen Hsiao)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、黃志平(Huang, Chi-Ping)、林哲弘(Che-Hung Lin)、林精湛(Ching-Chan Lin)、林維卿(Lin, Wei-Ching),附醫廠商計畫,一項隨機分配、雙盲、第2期試驗,評估腎細胞癌在接受一種血管內皮生長因子(VEGF)標靶治療後,使用二種不同起始劑量Lenvatinib (18mg相較於14mg QD)合併Everolimus (5mg QD)之安全性和療效,2017.1.1~2017.12.31 | 2017 . 01 |
8 | 臨床試驗與研究計畫,CMUH106-REC2-071,吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、葉士芃(Yeh, Su-Peng)、林精湛(Ching-Chan Lin)、陳冠亨(Guang-Heng Chen)、謝博帆(Po-Fan Hsieh)、林哲弘(Che-Hung Lin)、張議徽(Yi-Huei Chang)、林維卿(Lin, Wei-Ching),附醫廠商計畫,一項第三期、隨機分配、雙盲、安慰劑對照臨床試驗,以Pembrolizumab (MK-3475) 單一療法做為腎細胞癌腎切除術後的輔助性治療(KEYNOTE-564),2017.1.1~2017.12.31 | 2017 . 01 |